TerSera Therapeutics Growth, Revenue, Number of Employees and Funding
Navigation
Overview
Industry Ranking
State Ranking
Growjo 10k Ranking
Estimated Revenue & Financials
- TerSera Therapeutics's estimated revenue is currently $13.1M per year.
- TerSera Therapeutics's estimated revenue per employee is $120367
Employee Data
- TerSera Therapeutics has 109 Employees.
- TerSera Therapeutics grew their employee count by 51% last year.
- TerSera Therapeutics currently has 1 job openings.
Executive Contacts
| Name | Title |
|---|---|
| Lora Blackowicz | Vice President, Pharmacovigilance |
| Rick Crowley | Executive Vice President, Operations and Quality Assurance |
| Kenton Morneau | VP Information Technology |
| Vicky Papoutsis | EVP Business Development |
| Taryn Stinson | Director, Marketing |
| John Flood | Executive Director of Sales/National Accounts |
| Michael Henrick | Director |
| Marcy Komocsar | Executive Director, Clinical and Pharmacovigilance |
| Tom McGrady | Vice President Quality Assurance |
| Dyer Vann | Director of Marketing |
What Is TerSera Therapeutics?
TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Our mission is to market products which truly make a difference for patients. Our focus is to bring intelligent solutions to prescribers and patients who need better solutions. We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.
keywords:N/A109
Number of Employees
$13.1M
Revenue (est)
1
Current Jobs
51%
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
N/A
Type
Similar Companies
| Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
| N/A | 32 | 256% | ||
| $7.6M | 50 | 28% | ||
| $18.7M | 93 | -13% | ||
| $7.8M | 44 | 2% | ||
| $6.4M | 39 | 22% | ||
| $14.3M | 78 | 0% | ||
| $14.9M | 77 | 0% | ||
| $6.6M | 34 | -3% | ||
| $9.9M | 59 | -6% | ||
| $12.9M | 73 | 3% |
TerSera Therapeutics News
Goserelin Market SWOT Analysis including key players AstraZeneca, TerSera Therapeutics, Luye Pharma A Comprehensive Study exploring ...
Meloxicam Drug Market Latest Trend with Top key players: Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung ...
Plenty of Opportunities in Meloxicam Drug Market Studied in Detail along with Top Companies as Boehringer-Ingelheim, TerSera Therapeutics, ...